Form 8-K PORTOLA PHARMACEUTICALS For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Portola Pharma (PTLA) Tops Q3 EPS by 19c
November 9, 2015 4:48 PM ESTPortola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.05), $0.19 better than the analyst estimate of ($1.24). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $2.45 million.
For earnings history and earnings-related data on Portola Pharma (PTLA) click here.
... More